Article
Ghrelin variants influence development of body mass index and plasma levels of total cholesterol in dialyzed patients.
Clinical chemistry and laboratory medicine - 1 Jan 2007
Hubacek Jaroslav A, Bloudícková Silvie, Bohuslavová Romana, Táborský Petr, Polakovic Vladimír, Sazamová Magdaléna, Svítilová Eva, Vlasák Jicí, Sojková Iva, Ryba Miroslav, Knetl Petr, Ullrych Martin, Drahozal Radim, Pavuková Veronika, Pavlíková Beata, Fischlová Drahomíra, Mokrejsová Magdaléna, Chmelícková Hana, Pauchová Eva, Vyskocil Pavel, Nýdlová Zuzana, Kopenec Jaroslav, Fixa Petr, Hajný Jan, Bubenícek Petr, Syrovátka Petr, Zahálková Jana, Surel Stanislav, Hobzek Zdenek, Hrubý Ales, Suchanová Jana, Vanková Svetlana, Brabcová Jana, Viklický Ondrej
Abstract excerpt
BACKGROUND: Ghrelin is an endogenous hormone expressed predominantly in the stomach. Ghrelin controls growth hormone secretion and also affects the body's energy balance. We analyzed the association of ghrelin variants with body mass index (BMI), albumin as a marker of malnutrition and plasma lipids as risk factors for atherosclerosis in hemodialyzed patients, in whom malnutrition and accelerated atherosclerosis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
